Lebenthal Global Advisors »

Regeneron Pharmaceuticals shares owned by Lebenthal Global Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Lebenthal Global Advisors from 13F filings

Historical chart of Lebenthal Global Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Lebenthal Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Lebenthal Global Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $495k 641 771.89

More positions owned by Lebenthal Global Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Fidelity Comwlth Tr Nasdaq Compsit (ONEQ)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Vanguard Index Fds Value Etf (VTV)
J P Morgan Exchange Traded F Municipal Etf (JMUB)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Ishares Tr Core 60/40 Balan (AOR)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Spdr Series Trust State Street Spd (ONEY)
Spdr Series Trust State Street Spd (SJNK)

View all positions for Lebenthal Global Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management
Nuveen

View all funds holding Regeneron Pharmaceuticals